Wordt geladen...
EWS/FLI confers tumor cell synthetic lethality to CDK12 inhibition in Ewing sarcoma
Many cancer types are driven by oncogenic transcription factors that have been difficult to drug. Transcriptional inhibitors, however, may offer inroads into targeting these cancers. Through chemical genomics screening, we identified that Ewing sarcoma is a disease with preferential sensitivity to T...
Bewaard in:
| Gepubliceerd in: | Cancer Cell |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5846483/ https://ncbi.nlm.nih.gov/pubmed/29358035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2017.12.009 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|